Cerbios opens Swiss R&D center | Chemical & Engineering News
Volume 94 Issue 9 | p. 17 | Concentrates
Issue Date: February 29, 2016

Cerbios opens Swiss R&D center

Department: Business
Keywords: outsourcing, monoclonal antibody, active pharmaceutical ingredients
[+]Enlarge
Executives check out Cerbios’s new facilities.
Credit: Cerbios
A photo of executives checking out Cerbios’ new facilities.
 
Executives check out Cerbios’s new facilities.
Credit: Cerbios

The pharmaceutical services firm Cerbios-Pharma has opened an R&D center at its headquarters in Lugano, Switzerland, for the development of highly potent active pharmaceutical ingredients and monoclonal antibodies. The four-story, 1,120-m2 facility will house separate laboratories dedicated to biologics and small-molecule APIs manufactured to FDA’s current Good Manufacturing Practice quality standard.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment